News for Addus HomeCare Corporation (ADUS)

DaVita, Encompass Health, Option Care Health and Addus HomeCare have been highlighted in this Industry Outlook article.

Addus HomeCare (ADUS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Addus HomeCare (ADUS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Investors need to pay close attention to Addus HomeCare (ADUS) stock based on the movements in the options market lately.

Addus HomeCare Corporation. (NASDAQ:ADUS) Q4 2024 Earnings Conference Call February 25, 2025 9:00 AM ETCompany ParticipantsDru Anderson - Senior...

Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that Dirk Allison, Chairman and Chief Executive Officer and Brian

While the top- and bottom-line numbers for Addus HomeCare (ADUS) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Addus HomeCare (ADUS) delivered earnings and revenue surprises of 0% and 1.71%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the fourth quarter and year ended Decemb

Addus HomeCare (ADUS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Addus HomeCare (ADUS) possesses solid growth attributes, which could help it handily outperform the market.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Deckers Outdoor, Boot Barn, Addus HomeCare and The Ensign Group have been highlighted in this Screen of The Week article.

Besides Wall Street's top -and-bottom-line estimates for Addus HomeCare (ADUS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.

Here is how Addus HomeCare (ADUS) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.

Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare have been highlighted in this Industry Outlook article.

Addus HomeCare is a low-margin business with growth potential, but valuation estimates suggest a risk/reward imbalance for investors. See more on ADUS here.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please ...